Neogene Therapeutics

Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group.

Research Amsterdam, Netherlands ~26 employees

Work at Neogene Therapeutics in HR or recruiting? Claim this page

Employees
26
0% in the 3 months to Sep 2026
Revenue / employee
$76.9K
Revenue ~$2M
12-month attrition
56.5%
Tech: 28.9%
H1B filings, FY2024
1
Sponsors visas

Headcount trend

Neogene Therapeutics went from 94 employees in Oct 2024 to 26 in Sep 2026.

Org structure

Headcount by department

Other11
Operations7
Engineering7
Sales1

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Executive1

Peer reviews

Worked with someone at Neogene Therapeutics?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Neogene Therapeutics FAQ

How many employees does Neogene Therapeutics have?

Neogene Therapeutics has about 26 employees, unchanged over the 3 months to Sep 2026.

Does Neogene Therapeutics sponsor H1B visas?

Yes. Neogene Therapeutics filed 1 H1B (LCA) application in FY2024, according to the latest U.S. Department of Labor disclosures. It was for a Executive role.

What is Neogene Therapeutics's revenue per employee?

Neogene Therapeutics makes about $77K in revenue per employee, based on $2M annual revenue and 26 employees.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.